Unlabeled Use:
Contraindicated in:
Use Cautiously in:
CV: angina, arrhythmias, hypertension, myocardial ischemia, tachycardia.
Endo: hyperglycemia.
F and E: hypokalemia.
GI: nausea, vomiting.
Neuro: nervousness, restlessness, tremor, headache, insomnia.
Resp: pulmonary edema.
Drug-Drug:
Drug-Natural Products:
Asthma
Tocolysis (off-label)
Absorption: 3550% absorbed following oral administration but rapidly undergoes first-pass metabolism. Well absorbed following SUBQ administration.
Distribution: Unknown.
Metabolism/Excretion: Partially metabolized by the liver; 60% excreted unchanged by the kidneys.
Half-life: 5.7 hr.
(bronchodilation)
| ROUTE | ONSET | PEAK | DURATION |
|---|---|---|---|
| PO | within 60120 min | within 23 hr | 48 hr |
| SUBQ | within 15 min | within 0.51 hr | 1.54 hr |
NDC Code*